AT297236B - Verfahren zur Herstellung von neuen 4-Oxa-androstanen - Google Patents

Verfahren zur Herstellung von neuen 4-Oxa-androstanen

Info

Publication number
AT297236B
AT297236B AT416970A AT416970A AT297236B AT 297236 B AT297236 B AT 297236B AT 416970 A AT416970 A AT 416970A AT 416970 A AT416970 A AT 416970A AT 297236 B AT297236 B AT 297236B
Authority
AT
Austria
Prior art keywords
androstanes
oxa
new
production
Prior art date
Application number
AT416970A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AT297236B publication Critical patent/AT297236B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11BINFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B33/00Constructional parts, details or accessories not provided for in the other groups of this subclass
    • G11B33/02Cabinets; Cases; Stands; Disposition of apparatus therein or thereon
    • G11B33/04Cabinets; Cases; Stands; Disposition of apparatus therein or thereon modified to store record carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT416970A 1967-11-03 1968-10-31 Verfahren zur Herstellung von neuen 4-Oxa-androstanen AT297236B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68030867A 1967-11-03 1967-11-03

Publications (1)

Publication Number Publication Date
AT297236B true AT297236B (de) 1972-03-10

Family

ID=24730576

Family Applications (2)

Application Number Title Priority Date Filing Date
AT1062768A AT287932B (de) 1967-11-03 1968-10-31 Verfahren zur Herstellung von neuen 4-Oxa-androstanen
AT416970A AT297236B (de) 1967-11-03 1968-10-31 Verfahren zur Herstellung von neuen 4-Oxa-androstanen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT1062768A AT287932B (de) 1967-11-03 1968-10-31 Verfahren zur Herstellung von neuen 4-Oxa-androstanen

Country Status (14)

Country Link
AT (2) AT287932B (de)
BE (1) BE723189A (de)
BR (1) BR6803654D0 (de)
CH (1) CH505855A (de)
DK (1) DK131576C (de)
ES (1) ES359842A1 (de)
FI (1) FI48098C (de)
FR (2) FR1605466A (de)
GB (1) GB1247022A (de)
IE (1) IE33567B1 (de)
IL (1) IL30879A (de)
NL (1) NL6815623A (de)
NO (1) NO132101C (de)
SE (1) SE352360B (de)

Also Published As

Publication number Publication date
SE352360B (de) 1972-12-27
AT287932B (de) 1971-02-10
FR8435M (de) 1971-07-15
FI48098B (de) 1974-02-28
IL30879A (en) 1972-11-28
NL6815623A (de) 1969-05-06
IE33567B1 (en) 1974-08-21
DE1805857A1 (de) 1969-06-26
NO132101B (de) 1975-06-09
IE33567L (en) 1969-05-03
NO132101C (de) 1975-09-17
GB1247022A (en) 1971-09-22
ES359842A1 (es) 1970-06-16
BR6803654D0 (pt) 1973-01-16
IL30879A0 (en) 1968-12-26
CH505855A (de) 1971-04-15
DE1805857B2 (de) 1977-06-23
DK131576C (da) 1976-01-05
FI48098C (fi) 1974-06-10
BE723189A (de) 1969-04-30
DK131576B (da) 1975-08-04
FR1605466A (de) 1976-05-14

Similar Documents

Publication Publication Date Title
AT292301B (de) Verfahren zur Herstellung von neuen Copolymeren
AT297320B (de) Verfahren zur Herstellung von neuen Polyurethanen
CH501599A (de) Verfahren zur Herstellung von neuen Amidinoharnstoffen
CH499489A (de) Verfahren zur Herstellung von neuen Amino-monohalogen-phenyläthanolaminen
CH556816A (de) Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy-3-alkylaminopropanen.
AT305281B (de) Verfahren zur Herstellung von neuen 5-Chromenolestern
AT280601B (de) Verfahren zur Herstellung von neuen Copolymerisaten
AT277964B (de) Verfahren zur Herstellung von neuen Ketonitrilen
AT282577B (de) Verfahren zur Herstellung von neuen Fluorcyanoacrylaten
AT287193B (de) Verfahren zur Herstellung von neuen Penicillinen
AT291291B (de) Verfahren zur Herstellung von neuen Dithiophosphaten
AT301766B (de) Verfahren zur Herstellung von neuen 9α-unsubstituierten 11β-Chlor-19-nor-steroiden
AT283610B (de) Verfahren zur Herstellung von neuen 4-Oxasteroiden
AT278035B (de) Verfahren zur Herstellung von neuen Benzodioxan-N-methylcarbamaten
CH487145A (de) Verfahren zur Herstellung von neuen Butoxy-dimethylbenzamiden
AT316541B (de) Verfahren zur Herstellung von neuen Isoindolderivaten
AT311548B (de) Verfahren zur Herstellung von neuen Cyclopeptiden
AT279168B (de) Verfahren zur Herstellung von neuen Polyamiden
CH507226A (de) Verfahren zur Herstellung von neuen 3-Oxo-steroid-oximen
AT283593B (de) Verfahren zur Herstellung von neuen Penicillinen
AT279597B (de) Verfahren zur Herstellung von neuen Isocyanaten
AT301041B (de) Verfahren zur Herstellung von neuen 18-Methylensteroiden
AT323754B (de) Verfahren zur herstellung von neuen thiobenzoylaminoalkylbenzolsulfonylharnstoffen
CH520184A (de) Verfahren zur Herstellung von neuen Farbstoffen
AT273377B (de) Verfahren zur Herstellung von neuen Rifamycinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee